Heterosubtypic antibody recognition of the influenza virus hemagglutinin receptor binding site enhanced by avidity - Wikidata - thesis-toulmin - TriplyDB

Heterosubtypic antibody recognition of the influenza virus hemagglutinin receptor binding site enhanced by avidity

Heterosubtypic antibody recognition of the influenza virus hemagglutinin receptor binding site enhanced by avidity

http://www.wikidata.org/entity/Q27673861

about

Developing Universal Influenza Vaccines: Hitting the Nail, Not Just on the Head Structural characterization of viral epitopes recognized by broadly cross-reactive antibodies Influenza Human Monoclonal Antibody 1F1 Interacts with Three Major Antigenic Sites and Residues Mediating Human Receptor Specificity in H1N1 Viruses A recurring motif for antibody recognition of the receptor-binding site of influenza hemagglutinin Antibody Recognition of the Pandemic H1N1 Influenza Virus Hemagglutinin Receptor Binding Site A common solution to group 2 influenza virus neutralization Receptor mimicry by antibody F045–092 facilitates universal binding to the H3 subtype of influenza virus Alternative Recognition of the Conserved Stem Epitope in Influenza A Virus Hemagglutinin by a VH3-30-Encoded Heterosubtypic Antibody Conserved Neutralizing Epitope at Globular Head of Hemagglutinin in H3N2 Influenza Viruses Anti-Hemagglutinin Antibody Derived Lead Peptides for Inhibitors of Influenza Virus Binding Max Bergmann lecture protein epitope mimetics in the age of structural vaccinology Modified vaccinia virus ankara (MVA) as production platform for vaccines against influenza and other viral respiratory diseases Influenza hemagglutinin stem-fragment immunogen elicits broadly neutralizing antibodies and confers heterologous protection Large-scale analysis of B-cell epitopes on influenza virus hemagglutinin - implications for cross-reactivity of neutralizing antibodies.The breadth of cross sub-type neutralisation activity of a single domain antibody to influenza hemagglutinin can be increased by antibody valency.The Analysis of B-Cell Epitopes of Influenza Virus Hemagglutinin.Emerging antiviral strategies to interfere with influenza virus entry.Relating influenza virus membrane fusion kinetics to stoichiometry of neutralizing antibodies at the single-particle level Combination of the immunization with the sequence close to the consensus sequence and two DNA prime plus one VLP boost generate H5 hemagglutinin specific broad neutralizing antibodies.A broadly neutralizing human monoclonal antibody directed against a novel conserved epitope on the influenza virus H3 hemagglutinin globular head Characterization of a broadly neutralizing monoclonal antibody that targets the fusion domain of group 2 influenza A virus hemagglutinin.Glycan masking of hemagglutinin for adenovirus vector and recombinant protein immunizations elicits broadly neutralizing antibodies against H5N1 avian influenza viruses.Influenza virus antigenicity and broadly neutralizing epitopes.Strategies to guide the antibody affinity maturation process Comprehensive analysis of antibody recognition in convalescent humans from highly pathogenic avian influenza H5N1 infection Rational Design of an Epstein-Barr Virus Vaccine Targeting the Receptor-Binding Site Hemagglutinin stalk-based universal vaccine constructs protect against group 2 influenza A viruses.Broadly neutralizing antibodies against influenza viruses.Development and applications of single-cycle infectious influenza A virus (sciIAV).Heads, stalks and everything else: how can antibodies eradicate influenza as a human disease?A Perspective on the Structural and Functional Constraints for Immune Evasion: Insights from Influenza Virus.Increasing the breadth and potency of response to the seasonal influenza virus vaccine by immune complex immunization.From Original Antigenic Sin to the Universal Influenza Virus Vaccine.Heterosubtypic cross-reactivity of HA1 antibodies to influenza A, with emphasis on nonhuman subtypes (H5N1, H7N7, H9N2).Diversity of Functionally Permissive Sequences in the Receptor-Binding Site of Influenza Hemagglutinin.Computational design of trimeric influenza-neutralizing proteins targeting the hemagglutinin receptor binding site.In vitro evolution of an influenza broadly neutralizing antibody is modulated by hemagglutinin receptor specificity.Divergent Requirement of Fc-Fcγ Receptor Interactions for In Vivo Protection against Influenza Viruses by Two Pan-H5 Hemagglutinin Antibodies.In vivo dendritic cell targeting cellular vaccine induces CD4(+) Tfh cell-dependent antibody against influenza virus.Prospects of HA-based universal influenza vaccine.

P2860

Q26783897-3E9D0326-DAE5-4222-A700-EF3EEFDEEA0E Q26823492-88CD5FD1-DB16-424F-B3A3-DDE692708115 Q27675477-287EC6DF-5272-4633-AF31-DC5B5DD5677D Q27676298-EDCB9813-80D5-4EE7-BDF0-E403DD64EEBF Q27679927-3E3847ED-0CA7-4F0F-967B-4A2535BC6520 Q27680873-6EF5A543-DA36-4CEF-AD4D-18949448E66B Q27683156-3897191E-E837-49D5-9301-5C618C98BA1D Q27683187-EFBFD032-F5FA-4FAA-BFC2-A330C012C20B Q27683198-66F296E0-FFA2-472D-AA70-7CA8F42304CC Q28552622-594E6B1B-6837-45D9-A350-BE6CF366DDC6 Q30155145-CD522BAC-922B-4D5F-BFE0-8036523E1B83 Q30209342-0FDA00A2-DE44-46FA-8640-F953AF8AAAC4 Q30209769-3BCBF702-5210-4D71-9148-F55C1550EAA0 Q30217235-C85ECEB6-B5F2-41A5-9CE8-6FE27E2D6C51 Q30365366-9D85B049-12A4-4E9A-84B3-AF615D7FC64A Q30387177-4E339A4E-9EA3-4FAF-83EA-1E4A68ECF62A Q30432421-E635E3EC-17EC-4428-8D81-367E2763BBA4 Q30606286-2B1D922D-28A4-43BE-9022-F58AD7B21835 Q33724743-341139E7-EE84-413D-985C-56AF358D81F4 Q33743865-8697B557-07A7-4161-A194-85ABEF814ADC Q34594065-66371C67-4E66-4001-9217-0ABAA58C7D19 Q35132253-B5121092-7341-43E5-B565-21EE91596CB8 Q35685270-182F7F72-DA4A-414F-815F-E246155B250A Q35685300-34A0EA0F-B337-40C8-97AD-4A352E8DFF5C Q36392511-2DF3330A-590B-41AE-B38D-23CD784A1541 Q36590540-8192975F-6241-4C5C-9A45-A60A8DC1C9CA Q37252968-28F06357-C844-4B84-A223-FFB06E18432E Q37704975-86331CF0-6543-4C93-B7AE-A35FC4AB8D19 Q38556537-5CF4BF61-CB5C-4459-99DE-133D11CAFD3E Q38804059-CE40EBE1-D4F5-457B-93E8-FCA07CBCD1AD Q39397313-3F032E25-1DF0-41CA-AEE6-055045D6D9F1 Q40056879-A4A19160-E11C-46BE-9EA4-19D9BDC12B26 Q40059787-542D6568-6043-4C3F-93A1-5073D4F0AA99 Q40120056-CC4FFCCF-6B57-422B-89C7-1F2935AE488D Q40158695-7CB3043C-AAE0-4DC6-B2B4-B615019446C9 Q40163658-F9CF5E08-AC77-4E37-8C4C-85E3F5856CD9 Q40201534-515A3A4C-AD87-490A-989F-2BC26C5819F5 Q40279321-8C9FE488-FD8F-4E48-8203-9272BBCFE1E3 Q40507213-0F71083E-BE85-41FA-8799-0155C7B5767B Q41416400-29D10698-407F-416D-9AAC-F9F11FEF0FED

P2860

Heterosubtypic antibody recognition of the influenza virus hemagglutinin receptor binding site enhanced by avidity

http://www.wikidata.org/entity/Q27673861

description

2012 nî lūn-bûn

@nan

2012 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած

@hyw

2012 թվականի հոտեմբերին հրատարակված գիտական հոդված

@hy

2012年の論文

@ja

2012年論文

@yue

2012年論文

@zh-hant

2012年論文

@zh-hk

2012年論文

@zh-mo

2012年論文

@zh-tw

2012年论文

@wuu

name

Heterosubtypic antibody recogn ...... nding site enhanced by avidity

@ast

Heterosubtypic antibody recogn ...... nding site enhanced by avidity

@en

Heterosubtypic antibody recogn ...... nding site enhanced by avidity

@nl

type

label

Heterosubtypic antibody recogn ...... nding site enhanced by avidity

@ast

Heterosubtypic antibody recogn ...... nding site enhanced by avidity

@en

Heterosubtypic antibody recogn ...... nding site enhanced by avidity

@nl

prefLabel

Heterosubtypic antibody recogn ...... nding site enhanced by avidity

@ast

Heterosubtypic antibody recogn ...... nding site enhanced by avidity

@en

Heterosubtypic antibody recogn ...... nding site enhanced by avidity

@nl

P1433

Q27673861-4253390E-E76A-4A4D-97EB-FC88BB188A16

P1476

Q27673861-6C2662C4-4430-423B-B9FC-00567A7ADE0C

P2093

Q27673861-0D4FFC42-21CD-42D6-9281-76A204C75A80

Q27673861-1A92F213-2E94-438B-8AD4-51544951C26E

Q27673861-8B1AF30D-FE40-456E-8BC5-595BB7B0ACDA

Q27673861-C848A42A-DD76-4B6D-8AA7-0CA837E3C3BC

Q27673861-F4932F37-2DD5-4E66-AD5E-68AEF79096BA

P2860

Q27673861-0A3605D6-C327-4C5F-AA72-201DE851214C

Q27673861-0F677BA1-BD9B-4945-93A3-74EC1A4D3163

Q27673861-20E868AB-89A1-4A1A-8B20-88802778BAA8

Q27673861-22217F91-FC7D-4B25-BBE2-9A1A0C5303DF

Q27673861-2B23703D-0065-422E-B835-2BED5A7A1684

Q27673861-3024007A-7312-4713-A09C-8E19E020266A

Q27673861-34FC312E-EFD4-422A-B710-806F49BF636D

Q27673861-3A364DF3-581F-4309-8D27-A5C8E54E0FBA

Q27673861-4388F465-5EC1-4692-B8E6-5D4BA7746664

Q27673861-4B619432-F7A1-4726-A610-7174D7D23CE1

P304

Q27673861-7D2DA79C-3ECA-433B-9FA3-CF7EB026C791

P31

Q27673861-6E81CAD8-7025-47DA-94A9-12B065AE807A

P3181

Q27673861-F67195B8-450B-41B7-8CDD-B3485C1CF066

P356

Q27673861-2B064135-308C-4831-A30D-0CD9F9CD105F

P407

Q27673861-6D8962F8-7AA6-4245-BA04-446D08D2EA76

P433

Q27673861-E9C4DC9D-D3DB-4E0F-A6F2-2232786C0DC1

P478

Q27673861-71C87908-4DA0-40DA-9F22-F0EFFAD64666

P50

Q27673861-6F9038B9-E87E-40AB-BEFB-70B1761C2164

Q27673861-BA29BEB9-E48F-4CF7-92F5-EE5DB8ECB99B

P577

Q27673861-88DC7570-B5C0-4749-A4DF-8F54B23B9697

P5875

Q27673861-698ABF1B-D221-4737-92B2-F4333514C388

P698

Q27673861-8E4BD724-52EE-4111-9BB8-2FE61D68F11C

P921

Q27673861-CDAFE329-7CFD-4A1D-9A89-79B5AE375BB3

P932

Q27673861-20C9580B-D077-4D62-9632-BD36C90874D0

P3181

P356

PNAS.1212371109

P1433

Proceedings of the National Academy of Sciences of the United States of America

P1476

Heterosubtypic antibody recogn ...... nding site enhanced by avidity

@en

P2093

Ayato Takada

http://www.w3.org/2001/XMLSchema#string

Ian A Wilson

http://www.w3.org/2001/XMLSchema#string

Peter S Lee

http://www.w3.org/2001/XMLSchema#string

Reiko Yoshida

http://www.w3.org/2001/XMLSchema#string

Yasuhiko Suzuki

http://www.w3.org/2001/XMLSchema#string

P2860

Heterosubtypic neutralizing monoclonal antibodies cross-protective against H5N1 and H1N1 recovered from human IgM+ memory B cells

A highly conserved neutralizing epitope on group 2 influenza A viruses

MolProbity: all-atom structure validation for macromolecular crystallography

Structural and functional bases for broad-spectrum neutralization of avian and human influenza A viruses

Antibody recognition of a highly conserved influenza virus epitope

Broadly neutralizing antibodies against influenza virus and prospects for universal therapies

A complex of influenza hemagglutinin with a neutralizing antibody that binds outside the virus receptor binding site

An antibody that prevents the hemagglutinin low pH fusogenic transition

X-ray structure of the hemagglutinin of a potential H3 avian progenitor of the 1968 Hong Kong pandemic influenza virus

Structural Basis of Preexisting Immunity to the 2009 H1N1 Pandemic Influenza Virus

P304

17040-17045

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P3181

2980837

http://www.w3.org/2001/XMLSchema#string

P356

10.1073/PNAS.1212371109

http://www.w3.org/2001/XMLSchema#string

P407

P433

42

http://www.w3.org/2001/XMLSchema#string

P478

109

http://www.w3.org/2001/XMLSchema#string

P50

Damian C Ekiert

P577

2012-10-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

231742565

http://www.w3.org/2001/XMLSchema#string

P698

23027945

http://www.w3.org/2001/XMLSchema#string

P921

P932

3479480

http://www.w3.org/2001/XMLSchema#string